Page last updated: 2024-08-21

reticulin and incb-018424

reticulin has been researched along with incb-018424 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andraos, R; Baffert, F; Cozens, R; Dammassa, E; Dölemeyer, A; Ebel, N; Evrot, E; Hofmann, F; Murakami, M; Qian, Z; Radimerski, T; Roelli, C; Romanet, V; Sterker, D	1

Other Studies

1 other study(ies) available for reticulin and incb-018424

Article	Year
JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-15, Volume: 19, Issue:22 Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Disease Models, Animal; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Indoles; Janus Kinase 1; Janus Kinase 2; Mice; Nitriles; Panobinostat; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reticulin; Spleen; Splenomegaly; STAT5 Transcription Factor; Thrombocytosis	2013

Article

Year

JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-15, Volume: 19, Issue:22

Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Disease Models, Animal; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Indoles; Janus Kinase 1; Janus Kinase 2; Mice; Nitriles; Panobinostat; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reticulin; Spleen; Splenomegaly; STAT5 Transcription Factor; Thrombocytosis

2013